Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...

The US Food and Drug Administration (FDA) has approved belzutifan (Welireg, Merck) for adult and pediatric patients aged 12 ...

Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Find insight on Merck and Exelixis in the latest Market Talks covering Health Care.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

By Ludwig Burger FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

FRANKFURT (Reuters) -German pharmaceutical and specialty materials group Merck KGaA on Thursday guided more cautiously for ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...